Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
$62.8K Buy
73,601
+19,030
+35% +$20.7K ﹤0.01% 658
2022
Q4
$70.9K Sell
54,571
-9,336
-15% -$14.6K ﹤0.01% 497
2022
Q3
$114K Sell
63,907
-98,559
-61% -$245K ﹤0.01% 646
2022
Q2
$367K Buy
162,466
+97,280
+149% +$233K 0.01% 569
2022
Q1
$220K Buy
65,186
+4,699
+8% +$16.5K ﹤0.01% 598
2021
Q4
$292K Buy
+60,487
New +$457K 0.01% 595
2021
Q2
Sell
-172,751
Closed -$1.17M 760
2021
Q1
$1.17M Buy
+172,751
New +$1.15M 0.02% 257

Other funds holding OCGN

ETF Managers Group's OCGN Position: Q1 2023 in Review

ETF Managers Group increased its Ocugen (OCGN) stake by 35% in Q1 2023, buying an estimated $20.7K and bringing the position to 73,601 shares worth $62.8K. The position accounts for ﹤0.01% of the portfolio, ranked #658.

ETF Managers Group first reported a position in OCGN in Q1 2021 and has held it in 7 quarters since. The position peaked at $1.17M in Q1 2021. 103 funds tracked by Wall St. Rank hold OCGN as of Q1 2023.

  • ETF Managers Group held 73,601 shares of Ocugen worth $62.8K as of Q1 2023.
  • ETF Managers Group bought 19,030 Ocugen shares in Q1 2023, an estimated $20.7K.
  • Ocugen made up ﹤0.01% of ETF Managers Group's portfolio in Q1 2023, its #658 holding.
  • ETF Managers Group first reported a position in Ocugen in Q1 2021 and has held it in 7 quarters since.
  • ETF Managers Group's Ocugen position peaked at $1.17M in Q1 2021.
  • 103 funds tracked by Wall St. Rank held Ocugen as of Q1 2023.

Based on ETF Managers Group's 13F filing for Q1 2023, filed 18 Apr 2023.